Free Newsletter
Register for our Free Newsletters
Analysis, Inspection and Laboratory
Assisted/Independent Living
Clinical and Nursing Equipment
Design and Manufacture of Medical Equipment
Diagnostics Equipment, Monitoring and Test
Education, Training and Professional Services
Health Education and Patient Management
Health Estates Management
Healthcare Support and Information Services
Hygiene and Infection Control
IT and Communications in Healthcare
Medical Device Technology
Research and Development
Safety and Security
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone

French health authority report validates extracranial radiosurgery treatment

Accuray : 31 May, 2007  (New Product)
The French Haute Autorite de Santé (HAS) has issued a health technology assessment report validating extracranial radiosurgery treatment applications, particularly those delivered with Accuray’s CyberKnife Robotic Radiosurgery System.
The report deemed clinical benefits with these extracranial applications a significant improvement compared to existing alternatives (two on a scale of five, with one being the most significant).

Health technology assessment (HTA) is used to evaluate the impact of medical technology on patients and healthcare organizations by measuring safety, efficacy, cost effectiveness and efficiency. The HTA program works to provide decision makers with high-quality information and is frequently used to make important decisions regarding reimbursement. It is also used in many countries to guide purchasing decisions.

HTA is a strict process and sets a high standard for best practices in healthcare, in order to enhance safety, improve quality and reduce costs. HTA is now related to virtually every health policy process in France, and its role is becoming increasingly important within healthcare systems worldwide.

In recent years greater importance has been placed on HTA programs throughout the world in an effort to address rising healthcare costs and policy-makers desire for access to better decision-making processes. The report by the HAS was undertaken to define validated indications before patients start treatment using three CyberKnife Systems acquired thanks to a support by the French National Institute of Cancer (INCa).

“The positive HTA for extracranial Radiosurgery applications as part of the evaluation process of the CyberKnife System marks a milestone in the growing worldwide clinical acceptance of this groundbreaking technology” said Euan S Thomson, PhD, president and CEO of Accuray. “Validation by such an important, non-partisan authority is further demonstration that the market for Radiosurgery is continuing to broaden and that the CyberKnife System is meeting the needs of patients and clinicians worldwide.”

The HTA evaluation included analysis of 42 studies on the use of Radiosurgery for extracranial indications and concluded that there is sufficient expected clinical benefit for the curative or palliative treatment of patients with spine tumours, and primary and metastatic lung tumours.
Bookmark and Share
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
   Â© 2012
Netgains Logo